Our current study aims to explore the interaction of melatonin (MEL) with the monoaminergic system on the pathophysiology of affective disorders in Wistar rats. We mention here that, the role of monoaminergic transmission in the pathophysiology of affective disorders in humans is demonstrated in most recent reports. In this sense, our current work aims to explore the effect of melatonin (MEL) with or without imipramine (IMP) on levels of depression and anxiety in Wistar rats and would determine the role of MEL in modulating serotonin, noradrenaline and dopamine neurotransmission. From this point, twenty-four female Wister rats were divided into 4 groups of 6 animals and received subcutaneously during 4 weeks different doses of MEL (4 mg/kg), IMP (2 mg/kg) or MEL (4 mg/kg) + IMP (2 mg/kg). Behavioral performance especially anxiety and depression is measured in the open field (OFT), elevated plus maze (EPM) and forced swim test (FST). The anxiety-like and antidepressant-like effects were observed with MEL at 4 mg/Kg and IMP at 2 mg/Kg but the potentiating effect was more observed with the two combined molecules (MEL and IMP), since locomotors activity assessed by the OFT and EPM was not affected. These effects suggest that psychopharmacological actions of MEL are due, at least in part, to its ability to potentiate the central monoaminergic transmitter effects.
Introduction
There is a clear relationship between the affective disorders and brain levels of monoaminergic neurotransmitters serotonin (5-HT), noradrenalin (NA) and dopamine (DA). Depression is characterized by a decrease in 5-HT levels in the brain, particularly in the various structures of the limbic system. 5-HT-ergic system is also involved in the control of anxiety, and almost certainly, in the pathogenesis of all anxiety disorders. The fact that some antidepressants that increase brain neurotransmitter 5-HT-ergic relieve anxiety symptoms suggests that anxiety disorders share common mechanisms etiopathological with depression [1] .
The treatment of affective disorders by antidepressants, especially tricyclic antidepressants (TCA) is effected by activation of 5HT-ergic, by inhibiting the reuptake of 5-HT, inhibiting its degradation by MAO, or indirectly by blocking the α2-receptors NA-ergiques [2] . Among these antidepressants, IMP is known to block neuronal reuptake of NA and 5-HT. Its action extends to other neurotransmitters by inhibiting the reuptake of DA, cholinergic muscarinic receptors, histamine H1 receptors and α1-NA-ergic receptors.
Furthermore, the MEL is a hormone produced primarily by the pineal gland from its precursor, L-tryptophan (L-TRP) under the action of various enzymes.
The first step is the absorption of L-TRP by pinealocytes before its conversion Behaviorally, the relationship between anxiety and depressive disorders and MEL has been reported in many studies in various species including humans.
Significant changes in the rhythmic secretion of MEL have been detected in patients with affective disorders. It has been also shown a correlation between low levels of nocturnal MEL in subjects with major depression or panic disorder [3] .
This was also observed in subjects with melancholic depression. In contrast, higher levels of MEL than normal were observed in some patients during the manic phase [4] . The amplitude of the circadian rhythm of MEL who is blunted in patients with depression, is more important than changes in the level of absolute MEL. However, other studies have not permit to show a change in the MEL secretion profile in depressed patients; circulating levels of the hormone nor- Animal studies based on exogenous hormone intake have shown the involvement of MEL in the modulation of affective disorders. Thus, chronic administration of MEL showed anxiolytic effects and/or antidepressant in many models of anxiety and depression [5] . In rodents, except the study of Wong and Ong (2001) [6] , who reported sedative but not anxiolytic effect of MEL in rats, all works using animal models of anxiety, such as the passive avoidance test, open field test, light/dark box and elevated plus maze are consistent on the anti-anxiety character of the pineal hormone [7] . With respect to depression, studies show that the MEL exerts antidepressant action in the tail suspension test and forced swimming test (FST), which are considered predictive tests of the effectiveness of antidepressants in humans.
The interaction of MEL with aminergic systems in the regulation of affective disorders has been suggested by some studies. In rats and mice, MEL associated with reserpine, alkaloid antidepressant known to bind to the neurotransmitter storage vesicles, such as NA, 5-HT and DA, reduces the level of depression [8] .
In view of these data, the ability to increase antidepressant and anxiolytic effects of conventional drugs by MEL pretreatment may be a favorable option for patients resistant to drugs. Based on this concept, the aim of this study was to explore the putative synergistic effect of the IMP [9] and MEL on anxiety levels in the OFT and the EPM and on depression levels in the FST in Wistar rats. This study can be interesting because it will show a possible interaction of the pineal hormone with the aminergic system and therefore help to understand MEL action mechanisms. For this purpose, we undertake to explore the effect of 2 mg/kg of IMP alone or in combination with 4 mg/Kg of MEL on anxiety-like and depression-like levels in Wistar rats.
Material and Methods

Animals and Pharmacological Treatments
This experiment was used to study the effects of the pineal hormone in combination with IMP on female Wistar rats (from University Ibn Tofaïl) aged 8 to 9
weeks, initially weighing 120 ± 20 g and were grouped by six in cages 
Anxiety-Like Measurement
Open Field Test:
The OFT used in this study is conform to that previously reported [10] . The maze adopted is made of wood (100 cm × 100 cm) enclosed with 40 cm high walls and placed under strong illumination (100 W, 2 m above the apparatus). To eliminate any lingering olfactory cues, the apparatus was cleaned between each examination using 70% ethyl alcohol.
Depression-Like Measurement
The FST is an excellent maze used to assess the depressive-like behavior [12] .
Swimming sessions were conducted by placing the rat in individual glass cylinders (height = 50 cm; diameter = 30 cm) containing 30 cm of water at (23˚C ± 2˚C). During the session, rats were forced to swim for 5 min and the duration of immobility was measured. The latency to the first bout of immobility was also recorded starting immediately after placing the rats in the cylinder. A rat was considered immobile when it ceased all active behaviors (i.e. struggling, swimming and jumping) and remained passively floating or making minimal movements necessary to maintain the nostrils above water. High percent time floating is interpreted as an increased depressive-like response.
Quantitative Presentation of the Results and Statistics
The importance of behavioral responses of different experimental groups is determined by considering the control group in each experiment as the basal level (BL) number equal to 100%. The effects of different treatments were then calculated relative to this baseline. All data are expressed as the means ± standard error of the means (S.E.M.). To determine the differences between experimental groups statistical analysis was performed by analysis of variance (ANOVA) 1 st /2 nd order followed by a post-hoc tests (Fisher LSD) or Student test "t". Differences were considered significant when p < 0.05, very significant when p < 0.01 and highly significant when p < 0.001.
Result
Effect of MEL and/or IMP on Anxiety Level in Open Field Test
• Time spent in the central area (TCA) (Figure 1(a) ):
The results summarized in Figure 1 • Number of returns to the center (NRC) (Figure 1(b) ):
As for TCA, NRC parameter is also increased by the MEL, IMP and two asso- • Number of total squares (NTS) (Figure 1(c) 
Effect of MEL and/or IMP on Anxiety Level in Elevated Plus
Maze Test 
Effect of MEL and/or IMP on Depression-Like Level in Forced Swimming Test
• Effect on immobility time (TIM) (Figure 3(a) ):
In the FST, MEL, IMP and combined molecules strongly and significantly re- • Effect on struggling time (TST) (Figure 3 
Discussion
The present study aimed to investigate the interaction between MEL and IMP a tricyclic antidepressant. This has therefore allowed identifying a possible interaction of the pineal hormone with monoaminergic systems.
We showed in this study that chronic injection of MEL induced an anxiolytic effect in both OFT and EPM, since the animals of control group are less mobile in the environment of both anxiety paradigms. In FST rats treated with MEL show a significant reduction of TIM and increase of TDT, and therefore show significantly lower levels of depression with comparison to control animals.
These results confirm our previous observations showing that chronic administration of MEL produced anxiolytic and antidepressant activities [13] [14] . These results were also consistent with reports of majority studies which reported a significant reduction in anxiety behavior in animals treated with pharmacological doses of MEL, whatever the experimental conditions used, anxiogenic situations and animal species [7] [15] and are a good agreement with data reported in previous observations showing that chronic administration of MEL produced a real antidepressant-like effect [16] .
In this study, we have also shown that a very low dose of IMP (2 mg/kg) is capable of inducing strong anxiolytic and antidepressant activities when injected daily for several weeks. To our knowledge, this study is the first one to show an effect of low dose in comparison with other studies [17] . Recently, Detanico et al. In the same study, it was reported that the reduction of TIM induced by MEL is entirely suppressed by intra-amygdala administration of small amounts of 5-HT or by 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane a 5-HT2A/5-HT2C receptor agonist [20] . In humans, it has also been shown that MEL and buspirone exert a synergistic effect in the treatment of acute major depression, while MEL or buspirone remained without effects [21] . Buspirone is a non-benzodiazepine anxiolytic effects with partial agonists 5-HT-ergic 5HT1A, DA-ergic antagonists D2 and central α2-adrenergic blockers. These results may suggest that the effects of the MEL on the emotional behavior of rats in the FST paradigm could be due to an interaction of the hormone with central 5-HT neurotransmission [18] . The [18] . In addition, the reduction of the TIM in the FST is directly related to a reduction in activity of 5-HT2A receptors, and it was suggested that the observed antidepressant effects in the FST are regulated by 5-HT2A receptors [22] . In addition, it was shown that MEL may regulate the spontaneous efflux and evoked secretion of 5-HT2A receptors in the hippocampus, a major target of 5-HT-ergic antidepressants [23] .
The involvement of 5-HT2 receptors is also supported by the anxiolytic and antidepressant activities of agomelatine which is a structural analogue of MEL and antagonist of 5-HT2 receptors [19] .
Agomelatine is both an agonist of the MT1 and MT2 receptors and an anta- receptor, but not by idazoxan, α2-adrenergic antagonist receptors. Simultaneously, the MEL increases the TIM and swimming behavior decrease.
Indeed, in its mechanism of action, IMP affects many neurotransmitter systems known to be involved in the etiology of depression and anxiety by causing:
• Inhibition of the reuptake of NE. The continual conversion of IMP to its metabolite desipramine, which has extremely strong and relatively selective noradrenergic effects allows to moderate the effect of IMP on the reuptake of 5-HT. This mixture of IMP and desipramine provides a strong and simultaneous action on the inhibition of the reuptake of 5-HT and NA [9] .
• Reuptake and release of DA at the D1 and D2 receptors. Although this effect is weaker than the main effects of IMP on NA, 5-HT and Ach, it is no less important and is partially responsible for the therapeutic benefits of treatment with IMP. Improving brain DA-ergic activity is involved in the ability of the IMP to stimulate motor activity.
• Inhibition of cholinergic activity: IMP is an anticholinergic that acts by antagonizing the M2 muscarinic receptors. Blocking of these receptors is known to cause euphoria, potentially contributing to the effects of IMP on mood.
• Inhibition of α2-adrenergic receptors causing a general decrease in CNS ac- • Increased of BDNF levels part of the neurotrophic family and which are nerve growth factors. Studies suggest that depressed patients have reduced BDNF levels associated with a low hippocampal neurogenesis which is improved by IMP administration.
Increased expression of opioid μ receptors. It has been shown that IMP stimulates the expression of opioid μ receptors in rat forebrain and opioids are involved in improving of mood [30] .
The synergistic effect between MEL and IMP can also be explained by the modulation of central DA-ergic activity. Thus, it was shown that MEL has anti-DA-ergic activity by inhibiting the release of DA in specific areas of the CNS of mammals, including the hypothalamus, hippocampus and striatum [31] . This suggests that the MEL interfere with certain disorders involving DA. In this sense, it has been shown that depression induced behavior in mice is prevented by the MEL. The MEL antidepressant effect itself is prevented by a pretreatment of mice with haloperidol (non-selective antagonist of DA receptors), the SCH-23390 (selective D1 receptor antagonist) and sulpiride (selective D2 receptors antagonist) [32] . This study clearly indicates that the MEL antidepressant effect may be mediated by interaction with the DA-ergic system through activation of D1 and/or D2 receptors [32] . Paradoxically, MEL reinforces the antidepressant effect of reserpine by further reducing the TIM in the FST in mice and rats [8] . However, it is known that reserpine is an inhibitor of neurotransmission of 5-HT, NA and DA, until depletion of monoamines stocks and this inhibition is involved in depression in the human. After the text edit has been completed, the paper is ready for the template. Duplicate the template file by using the Save As command, and use the naming convention prescribed by your journal for the name of your paper. In this newly created file, highlight all of the contents and import your prepared text file. You are now ready to style your paper.
Conclusion
To summarize, our data from numerous research show an implication of MEL and interaction between MEL and IMP in modulation of anxiety-like and depression-like behavior in rats but do not demonstrate any mechanism of action.
All these data suggest that alteration of the sensitivity of certain monoaminergic receptors by MEL could be responsible for the interaction between MEL and IMP and, thence, to explain the mechanism action of MEL in this interaction.
Additional understanding of melatonin association with other neurotransmitters may contribute to demonstrate a more important contribution of pineal hormone to affective disorder.
